Clinical Trials Logo

Chronic Glomerulonephritis clinical trials

View clinical trials related to Chronic Glomerulonephritis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00914524 Completed - Clinical trials for Diabetic Nephropathy

Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic Nephropathy

Start date: January 2005
Phase: Phase 2
Study type: Interventional

The treatment period was 16 weeks, the initial dose, 5 mg, was unforcedly titrated to 10 mg, 20 mg and 40 mg after confirming tolerance at weeks 4, 8 and 12. The primary endpoint for efficacy was the change in the urinary protein/creatinine ratio from baseline to the end of treatment. The secondary endpoint was creatinine clearance (Ccr).